High-sensitivity assay for monitoring ESR1 mutations in circulating cell-free DNA of breast cancer patients receiving endocrine therapyLaura Lupini, Massimo Negrini, A. Moretti et al.|Scientific Reports|2018Cited by 23
HER2-Positive Lobular Versus Ductal Carcinoma of the Breast: Pattern of First Recurrence and Molecular InsightsLucia Da Ros, Antonio Frassoldati, A. Moretti et al.|Clinical Breast Cancer|2018Cited by 13
A post-reaction regimen for CRC patients manifesting hypersensitivity to oxaliplatin : an effective alternative not to rule out an important option of treatmentC. Nisi, Antonio Frassoldati, Lucia Da Ros et al.|Annals of Oncology|2015Cited by 1
Can irinotecan dose reduction according to ugt1a1 genotype avoid severe toxicities?Francesca Daniel, Antonio Frassoldati, Lorenzo Belluomini et al.|Annals of Oncology|2016Cited by 1